Annual funding volumes of trastuzumab
28 July 2020
Dear [name and contact details withheld]
REQUEST FOR INFORMATION
Thank you for your request dated 30 June under the Official Information Act 1982 (OIA) for information relating to trastuzumab. You asked for:
“the most recent data on annual volumes of trastuzumab, ideally split by vial size but if not then in total mg per annum.”
The data you have requested is listed in the table below as volumes of trastuzumab funded. The data for 2020 is current up until the end of May 2020.
|
Chemical name |
Formulation |
Brand name |
Calendar year |
Units – number of vials |
|---|---|---|---|---|
|
Trastuzumab |
Inj 440 mg vial |
Herceptin |
2015 |
1,811.09 |
|
Trastuzumab |
Inj 440 mg vial |
Herceptin |
2016 |
1,912.3 |
|
Trastuzumab |
Inj 440 mg vial |
Herceptin |
2017 |
1,789.49 |
|
Trastuzumab |
Inj 440 mg vial |
Herceptin |
2018 |
1,413.27 |
|
Trastuzumab |
Inj 440 mg vial |
Herceptin |
2019 |
1,401.4 |
|
Trastuzumab |
Inj 440 mg vial |
Herceptin |
2020 |
722.85 |
|
Trastuzumab |
Inj 150 mg vial |
Herceptin |
2015 |
6,960.36 |
|
Trastuzumab |
Inj 150 mg vial |
Herceptin |
2016 |
7,893.77 |
|
Trastuzumab |
Inj 150 mg vial |
Herceptin |
2017 |
8,702.97 |
|
Trastuzumab |
Inj 150 mg vial |
Herceptin |
2018 |
8,017.33 |
|
Trastuzumab |
Inj 150 mg vial |
Herceptin |
2019 |
8,844.92 |
|
Trastuzumab |
Inj 150 mg vial |
Herceptin |
2020 |
3,074.1 |
|
Chemical name |
Formulation |
Brand name |
Calendar year |
Units – mg |
|---|---|---|---|---|
|
Trastuzumab |
Inj 1 mg for ECP |
Baxter |
2015 |
1,824,241.5 |
|
Trastuzumab |
Inj 1 mg for ECP |
Baxter |
2016 |
2,017,107 |
|
Trastuzumab |
Inj 1 mg for ECP |
Baxter |
2017 |
2,004,816 |
|
Trastuzumab |
Inj 1 mg for ECP |
Baxter |
2018 |
2,322,975 |
|
Trastuzumab |
Inj 1 mg for ECP |
Baxter |
2019 |
2,019,095 |
|
Trastuzumab |
Inj 1 mg for ECP |
Baxter |
2020 |
753,092 |
[ECP = Extemporaneously Compounded Preparations]
We trust that this information answers your queries. We are making our information more freely available, so we will now publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this.
Yours sincerely
Rachel Read
Manager, Policy and Government Services